|
🐜
|
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
40 auth.
L. Peyrin-Biroulet,
W. Sandborn,
B. Sands,
W. Reinisch,
W. Reinisch,
W. Bemelman,
R. Bryant,
G. D'Haens,
I. Dotan,
Marla C. Dubinsky,
B. Feagan,
G. Fiorino,
R. Gearry,
S. Krishnareddy,
P. Lakatos,
...
E. Loftus,
P. Marteau,
P. Munkholm,
T. Murdoch,
I. Ordás,
R. Panaccione,
R. Riddell,
J. Ruel,
D. Rubin,
M. Samaan,
C. Siegel,
M. Silverberg,
J. Stoker,
S. Schreiber,
S. Travis,
G. V. Assche,
G. Assche,
S. Danese,
J. Panés,
G. Bouguen,
S. O’Donnell,
B. Pariente,
S. Winer,
S. Hanauer,
J. Colombel
|
10 |
2015 |
10
🐜
|
|
🐜
|
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.
10 auth.
K. Bambha,
W.Ray Kim,
J. Talwalkar,
Heidi Torgerson,
J. Benson,
T. Therneau,
...
E. Loftus,
B. Yawn,
E. Dickson,
L. Melton
|
8 |
2003 |
8
🐜
|
|
🦁
|
Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis
E. Loftus,
S. Kane,
D. Bjorkman
|
7 |
2004 |
7
🦁
|
|
🦁
|
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
19 auth.
E. Loftus,
J. Panés,
A. Lacerda,
L. Peyrin-Biroulet,
G. D'Haens,
R. Panaccione,
W. Reinisch,
E. Louis,
Minhu Chen,
H. Nakase,
...
J. Begun,
B. Boland,
C. Phillips,
M. Mohamed,
Jianzhong Liu,
Z. Geng,
Tianqing Feng,
E. Dubcenco,
J. Colombel
|
7 |
2023 |
7
🦁
|
|
🐜
|
Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
39 auth.
C. Le Berre,
L. Peyrin-Biroulet,
W. Sandborn,
J. Colombel,
D. Rubin,
Y. Chowers,
W. Reinisch,
S. Schreiber,
M. Allez,
G. D'Haens,
Subrata Ghosh,
I. Koutroubakis,
Peter Gibson,
J. Halfvarson,
A. Hart,
...
A. Kaser,
P. Munkholm,
W. Kruis,
S. Vermeire,
E. Loftus,
M. Lukáš,
G. Mantzaris,
C. O'Morain,
J. Panés,
G. Rogler,
A. Spinelli,
B. Sands,
Aswhin N. Ananthakrishnan,
S. Ng,
D. Sachar,
S. Travis,
F. Steinwurz,
D. Turner,
P. Dulai,
V. Jairath,
I. Dotan,
M. Abreu,
R. Panaccione,
S. Danese
|
6 |
2021 |
6
🐜
|
|
🐜
|
Higher vs Standard Adalimumab Induction Dosing Regimens and 2 Maintenance Strategies: Randomized SERENE CD Trial Results.
22 auth.
G. D'Haens,
W. Sandborn,
E. Loftus,
S. Hanauer,
S. Schreiber,
L. Peyrin-Biroulet,
R. Panaccione,
J. Panés,
F. Baert,
J. Colombel,
...
M. Ferrante,
E. Louis,
A. Armuzzi,
Qian Zhou,
V. Goteti,
N. Mostafa,
T. Doan,
J. Petersson,
T. Finney-Hayward,
A. Song,
A. Robinson,
S. Danese
|
5 |
2022 |
5
🐜
|
|
🦁
|
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.
17 auth.
E. Loftus,
J. Colombel,
K. Takeuchi,
Xiang Gao,
R. Panaccione,
S. Danese,
M. Dubinsky,
S. Schreiber,
D. Ilo,
T. Finney-Hayward,
...
Wen Zhou,
C. Phillips,
Y. S. Gonzalez,
L. Shu,
Xuan Yao,
Qing Zhou,
S. Vermeire
|
5 |
2022 |
5
🦁
|
|
🐢
|
Upadacitinib Was Efficacious and Well Tolerated Over 30 Months in Patients with Crohn's Disease in the CELEST Extension Study.
7 auth.
G. D'Haens,
J. Panés,
E. Louis,
A. Lacerda,
Qian Zhou,
John Liu,
...
E. Loftus
|
5 |
2021 |
5
🐢
|
|
🐜
|
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease
24 auth.
R. Panaccione,
A. Steinhart,
B. Bressler,
R. Khanna,
J. K. Marshall,
L. Targownik,
W. Afif,
A. Bitton,
M. Borgaonkar,
U. Chauhan,
...
B. Halloran,
Jennifer L Jones,
E. Kennedy,
G. Leontiadis,
E. Loftus,
J. Meddings,
P. Moayyedi,
S. Murthy,
S. Plamondon,
G. Rosenfeld,
D. Schwartz,
C. Seow,
Chadwick Williams,
Charles N. Bernstein
|
5 |
2018 |
5
🐜
|
|
🐜
|
Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient Sample
8 auth.
F. Bazerbachi,
Tarek Sawas,
E. Vargas,
S. Haffar,
P. Deepak,
J. Kisiel,
...
E. Loftus,
Barham K. Abu Dayyeh
|
4 |
2018 |
4
🐜
|
|
🐜
|
Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease
8 auth.
R. Tariq,
Tausif A. Syed,
Devvrat Yadav,
L. Prokop,
Siddharth Singh,
E. Loftus,
...
D. Pardi,
S. Khanna
|
4 |
2021 |
4
🐜
|
